Allopurinol is an effective medication commonly used to treat gout, a condition where high levels of uric acid in the body result in crystals forming in the joints and skin. Allopurinol can also be used to treat uric acid stones and kidney disease caused by high levels of uric acid. It is a prescription-only medicine and should only be used under medical supervision. Allopurinol reduces the production of uric acid and lowers the uric acid level in the body.

The global Allopurinol Tablets market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Allopurinol Tablets volume and value at global level, regional level and company level. From a global perspective, this report represents overall Allopurinol Tablets market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Allopurinol Tablets in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Allopurinol Tablets manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Casper Pharma
Dr. Reddys Laboratories
Teva
Zydus Pharmaceuticals
Mylan
Sun Pharmaceutical
APOTEX
NorthStar Healthcare
Ipca Laboratories
Accord Healthcare

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
100 mg
300 mg

Segment by Application
Gout
Kidney Stones